| 000 | 01030 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516151633.0 | ||
| 264 | 0 | _c20131122 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1529-0131 | ||
| 024 | 7 |
_a10.1002/art.38013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Steenbergen, H W | |
| 245 | 0 | 0 |
_aThe preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed? _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cSep 2013 |
||
| 300 |
_a2219-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProdromal Symptoms |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHuizinga, T W J | |
| 700 | 1 | _avan der Helm-van Mil, A H M | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 65 _gno. 9 _gp. 2219-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.38013 _zAvailable from publisher's website |
| 999 |
_c22763249 _d22763249 |
||